PERIDOT ACQUISITION CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2020
The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote the Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.
Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.
The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public Shares.
The Company will have until September 28, 2022 to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity and Capital Resources
As of December 31, 2020, the Company had approximately $1.0 million in its operating bank accounts and working capital of approximately $1.0 million.
Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through a contribution of $25,000 from Sponsor to cover certain offering costs in exchange for the issuance of the Founder Shares, the loan of up to $300,000 from the Sponsor pursuant to the Note (see Note 6), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Note was repaid on September 28, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors will fund, and have the means to provide the Company Working Capital Loans (see Note 6). As of December 31, 2020, there were no amounts outstanding under any Working Capital Loan.
Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
NOTE 2 — RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
The Company previously accounted for its outstanding Public Warrants (as defined in Note 4) and Private Placement Warrants issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of ordinary shares, all holders of the warrants would be entitled to receive cash for their warrants (the “tender offer provision”).
In connection with the audit of the Company’s financial statements for the period ended December 31, 2020, the Company’s management further evaluated the warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40- 15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on management’s evaluation, the Company’s audit committee, in consultation with management and after discussion with the Company’s independent registered public accounting firm, concluded that the Company’s Private Placement Warrants are not indexed to the Company’s ordinary shares in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. In addition, based on management’s evaluation, the Company’s audit committee, in consultation with management and after discussion with the Company’s independent registered public accounting firm, concluded the tender offer provision included in the warrant agreement fails the “classified in shareholders’ equity” criteria as contemplated by ASC Section 815-40-25.
As a result of the above, the Company should have classified the warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period.
The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash flows or cash.
The following table reflects the Company’s balance sheet, statement of operations, and statement of cash flows as of and for the periods indicated below.
| | | | | | | | | | | | |
| | As Previously Reported | | | Adjustments | | | As Restated | |
Balance sheet as of September 28, 2020 (audited) | | | | | | | | | | | | |
Warrant Liability | | $ | — | | | $ | 18,400,000 | | | $ | 18,400,000 | |
Class A Ordinary Shares Subject to Possible Redemption | | | 285,953,420 | | | | (18,400,000 | ) | | | 267,553,420 | |
Class A Ordinary Shares | | | 140 | | | | 184 | | | | 324 | |
Additional Paid-in Capital | | | 5,004,002 | | | | 693,663 | | | | 5,697,665 | |
Accumulated Deficit | | | (5,000 | ) | | | (693,847 | ) | | | (698,847 | ) |
Balance sheet as of September 30, 2020 (unaudited) | | | | | | | | | | | | |
Warrant Liability | | $ | — | | | $ | 18,860,000 | | | $ | 18,860,000 | |
Class A Ordinary Shares Subject to Possible Redemption | | | 285,947,270 | | | | (18,860,000 | ) | | | 267,087,270 | |
Class A Ordinary Shares | | | 141 | | | | 188 | | | | 329 | |
Additional Paid-in Capital | | | 5,010,151 | | | | 1,153,659 | | | | 6,163,810 | |
Accumulated Deficit | | | (11,151 | ) | | | (1,153,847 | ) | | | (1,164,998 | ) |
Balance sheet as of December 31, 2020 (audited) | | | | | | | | | | | | |
Warrant Liability | | $ | — | | | $ | 40,940,000 | | | $ | 40,940,000 | |
Class A Ordinary Shares Subject to Possible Redemption | | | 285,571,850 | | | | (40,940,000 | ) | | | 244,631,850 | |
Class A Ordinary Shares | | | 144 | | | | 410 | | | | 554 | |
Additional Paid-in Capital | | | 5,385,681 | | | | 23,233,437 | | | | 28,619,118 | |
Accumulated Deficit | | | (386,565 | ) | | | (23,233,847 | ) | | | (23,620,412 | ) |
Statement of Operations from July 31, 2020 (inception) to September 30, 2020 (unaudited) | | | | | | | | | | | | |
Change in fair value of warrant liability | | $ | — | | | $ | (460,000 | ) | | $ | (460,000 | ) |
Net loss | | | (11,151 | ) | | | (1,153,847 | ) | | | (1,164,998 | ) |
Weighted average shares outstanding of Class A redeemable ordinary shares | | | 30,000,000 | | | | — | | | | 30,000,000 | |
Basic and diluted net loss per share, Class A | | | (0.00 | ) | | | — | | | | (0.00 | ) |
Weighted average shares outstanding of Class B non- redeemable ordinary shares | | | 7,500,000 | | | | — | | | | 7,500,000 | |
Basic and diluted net loss per share, Class B | | | (0.00 | ) | | | (0.16 | ) | | | (0.16 | ) |
Statement of Operations from July 31, 2020 (inception) to December 31, 2020 (audited) | | | | | | | | | | | | |
Change in fair value of warrant liability | | $ | — | | | $ | 22,540,000 | | | $ | (22,540,000 | ) |
Net loss | | | (386,565 | ) | | | (23,233,847 | ) | | | (23,620,412 | ) |
Weighted average shares outstanding of Class A redeemable ordinary shares | | | 30,000,000 | | | | — | | | | 30,000,000 | |
Basic and diluted net earnings per share, Class A | | | 0.00 | | | | — | | | | 0.00 | |
Weighted average shares outstanding of Class B non-redeemable ordinary shares | | | 7,500,000 | | | | — | | | | 7,500,000 | |
Basic and diluted net loss per share, Class B | | | (0.06 | ) | | | (3.10 | ) | | | (3.16 | ) |
Cash Flow Statement for the Period from July 31, 2020 (inception) to September 30, 2020 (unaudited) | | | | | | | | | | | | |
Net income (loss) | | $ | (11,151 | ) | | $ | (1,153,847 | ) | | $ | (1,164,998 | ) |
Change in fair value of warrant liability | | | — | | | | (460,000 | ) | | | (460,000 | ) |
Offering costs allocated to warrant liability | | | — | | | | 693,847 | | | | 693,847 | |
Initial classification of warrant liability | | | — | | | | 18,400,000 | | | | 18,400,000 | |
Initial classification of common stock subject to possible redemption | | | 285,953,420 | | | | (18,400,000 | ) | | | 267,553,420 | |
Change in value of common stock subject to possible redemption | | | (6,150 | ) | | | (460,000 | ) | | | (466,150 | ) |
Cash Flow Statement for the Period from July 31, 2020 (inception) to December 31, 2020 (audited) | | | | | | | | | | | | |
Net income (loss) | | | (386,565 | ) | | | (23,233,847 | ) | | | (23,620,412 | ) |
Change in fair value of warrant liability | | | — | | | | 22,540,000 | | | | 22,540,000 | |
Offering costs allocated to warrant liability | | | — | | | | 693,847 | | | | 693,847 | |
Initial classification of warrant liability | | | — | | | | 18,400,000 | | | | 18,400,000 | |
Initial classification of common stock subject to possible redemption | | | 285,953,420 | | | | (18,400,000 | ) | | | 267,553,420 | |
Change in value of common stock subject to possible redemption | | | (381,570 | ) | | | (22,540,000 | ) | | | (22,921,570 | ) |
F-8